Clinical Trials Browser

Phase 1/2 × Dermatofibrosarcoma × Imatinib Mesylate × Clear all

NCT00122473 2011-07-29

Imatinib in Dermatofibrosarcoma Protuberans (DFSP)

Phase 1/2 Completed

Dermatofibrosarcoma